Thrombocytopenia
Immune thrombocytopenia featured most prominently at the Meeting but new data was presented for several forms of the disease.
The tranexamic acid and placebo groups did not differ in occurrence of thrombotic events or veno-occlusive disease.
The Fellow on Call group characterizes HIT, discusses the risk factors for HIT antibody formation, and much more.
The group kicks off their cytopenias journey by delineating their approach for managing thrombocytopenia.
According to group, whenever a patient with heparin exposure has a new thrombotic event, you should consider HIT.
According to a recent study published in the American Journal of Obstetrics and Gynecology, the children of women who ...
According to a presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, momelotinib was ...
Hematology is the study of diseases related to the blood, including diagnosis, pathology, treatment, prevention, and ...
A study recently published in NEJM found that a woman’s platelet count may naturally decline during pregnancy, and ...
Advertisement
Expert Interviews on Hematology
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.